Jpmorgan Chase & Co »

Q32 Bio shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $165k 3.7k 44.62
2024-06-30 $47k 2.6k 17.95
2024-03-31 $868 51 17.04

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
BlackRock
BlackRock
Arch Venture Corp
Eventide Asset Management
Harvard Management Company
Vanguard Group
Geode Capital Management
Woodline Partners
State Street Corporation
Point72 Asset Management
Platinum Investment Mangement
Ensign Peak Advisors

View all funds holding Q32 Bio